Skip to main content

Martin Wilson

Equibles does not estimate personal net worth.

Get an email with a short summary when Rocket Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get RCKT alerts

About Martin Wilson

Martin Wilson is recorded as General Counsel at Rocket Pharmaceuticals, Inc. (RCKT). The newest filing on record that lists Martin Wilson as General Counsel at Rocket Pharmaceuticals, Inc. (RCKT) is dated April 6, 2026. The proxy statement of Rocket Pharmaceuticals, Inc. reports total compensation of $3,397,880 for Martin Wilson in fiscal 2025, including a base salary of $488,279. Disclosed compensation is on record for 3 fiscal years. Rocket Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rocket Pharmaceuticals, Inc. includes Gaurav Shah (CEO and Board Member), Aaron Ondrey (CFO), Carlos Garcia-Parada (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at Rocket Pharmaceuticals, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Rocket Pharmaceuticals, Inc. (RCKT) $488,279 $3,397,880
2024 Rocket Pharmaceuticals, Inc. (RCKT) $452,560 $2,113,954
2021 Rocket Pharmaceuticals, Inc. (RCKT) $37,727 $1,560,950

Recent activity

No call appearances or filed executive changes recorded yet.